The Efficacy and Safety of Cetuximab β plus Tislelizumab and Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CTC-LAESCC): single-arm, phase II study (ESMO Asia 2026) - Oct 1, 2026 - Abstract #1064P; Pres time: Dec 4, 2026; 05:15 PM - 06:15 PM; Location: Poster area (Exhibition); No abstract available
Clinical • Metastases • P2 data • Esophageal Squamous Cell Carcinoma • Oncology • Squamous Cell Carcinoma
|
|
Xiuyong Liao; Huan Shi; Jingjing Wang; Jiali Liu; Meijuan Pang; Linfeng Zhong; Huan Zhao; Jiajia Gong; Enqiang Liu; Yi Qing; Jiangrong Du; Meifeng Xu; Xiajie Wei; Dong Wang
|